0001626644
Company
Odyssey Health, Inc.
Surgical & Medical Instruments & Apparatus · ODYY
follow-on
priced
OTC
EFFECT
Filing Timeline
SEC EDGAR
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2025-12-30 · 0001683168-25-009405
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-12-30 · 9999999995-25-003967
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2025-12-19 · 0001683168-25-009284
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
2025-08-20 · 0001683168-25-006334
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-08-20 · 9999999995-25-002688
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-08-15 · 0001683168-25-006234
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2025-08-15 · 0001683168-25-006245
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2025-08-05 · 0001683168-25-005648
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2022-08-09 · 0001683168-22-005450
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-08-09 · 9999999995-22-002308
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
2022-07-29 · 0001683168-22-005212
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2021-04-21 · 0001683168-21-001481
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2020-12-08 · 0001683168-20-004197
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2020-12-04 · 9999999995-20-003412
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2020-11-23 · 0001683168-20-004069
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2015-07-30 · 9999999995-15-002109
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-07-23 · 0001019687-15-002841
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-07-01 · 0001019687-15-002589
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-06-15 · 0001019687-15-002399
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-06-02 · 0001019687-15-002226
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-04-29 · 0001019687-15-001675
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2015-03-16 · 0001019687-15-000978
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Odyssey Health, Inc. is an emerging growth company seeking to register 14,750,000 shares of common stock for resale by selling stockholders who participated in a 2014 private placement. The offering involves significant risks, including lack of operating history, dependence on a single product line, and uncertainties around stock listing. The company aims to list its shares on a national exchange or OTC Bulletin Board but faces no guarantees of approval.
2015-02-26 · 0001019687-15-000737
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $0.50 · 14,750,000 shares · Gross proceeds $7,375,000
Common stock, par value $.001 per share · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
Odyssey Health, Inc. is registering 14,750,000 shares of common stock for resale by selling stockholders who purchased shares in a private placement in June and July 2014. The company, formed in March 2014, focuses on distributing athletic enhancement products in the U.S. The offering is structured as an emerging growth company under the JOBS Act, with shares initially priced at $0.50 until potential listing on a national exchange or OTC Bulletin Board. The registration statement includes risk factors related to the speculative nature of the investment, lack of public market, and uncertainties around listing approvals.
2014-12-12 · 0001019687-14-004699
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $0.50 · 14,750,000 shares · Gross proceeds $0.00
Common stock, par value $.001 per share · Selling stockholders only · Use of proceeds To cover offering expenses · Underwriters selling stockholders
Odyssey Group International, Inc. (OGI) is an emerging growth company formed in March 2014 to distribute athletic enhancement products in the U.S. This S-1 filing registers 14,750,000 shares of common stock for resale by selling stockholders who participated in a June-July 2014 private placement. The offering price is $0.50 per share until the stock is listed on an exchange or OTC Bulletin Board. The company has no operating history, no public trading market, and faces significant risks related to its early-stage operations, reliance on management, and market acceptance.
2014-12-08 · 0001019687-14-004616
Comparable Deals
4 comparable deals
Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 4 using nearest neighbors.
Recent News
No recent news stored for this issuer.